DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4%- diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 4% gel
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4%

Directions for use

sd

Sincerus Florida. Adverse reactions

df

Active, inactive

cv

NDC 72934-1072-2 DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4%
Gel 30 gm

rs

DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 4%
diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 4% gel
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-1072
Route of Administration TOPICAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1) DICLOFENAC SODIUM 3 g  in 100 g
Product Characteristics
Color white (clear gel) Score
Shape Size
Flavor Imprint Code
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:72934-1072-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 05/07/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
Name Address ID/FEI Business Operations
Sincerus Florida, LLC 080105003 manufacture(72934-1072)

Revised: 5/2019
Document Id: 883dde9f-e5de-69d9-e053-2a95a90a2c24
Set id: 883dde9f-e5dd-69d9-e053-2a95a90a2c24
Version: 1
Effective Time: 20190506
Sincerus Florida, LLC